30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Pascal Deschatelets

Track

Insider profile

Currently holds a position at Apellis Pharmaceuticals Inc

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 34% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-Founder, Chief Operating Officer Apellis Pharmaceuticals Inc Jan. 1, 2016 -
Chief Operating Officer Apellis Pharmaceuticals Inc Sept. 1, 2009 - Jan. 1, 2016
Pascal Deschatelets's trades of Apellis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-23 2026-01-22
S Sale
98,173 +13.6%
329.34
US$3,820,180 		98,173 +13.6% 329.34 US$3,820,180
2026-01-22 2026-01-22
PrS Proposed sale
31,856
269.16
US$439,981 		31,856 269.16 US$439,981
2026-01-21 2026-01-20
S Sale
36,650 -6.5%
424.43
US$1,214,990 		36,650 -6.5% 424.43 US$1,214,990
2026-01-20 2026-01-20
PrS Proposed sale
909
19.79
US$17,992 		909 19.79 US$17,992
2026-01-15 2026-01-13
S Sale
2,277 -0.2%
22.19
US$50,520 		2,277 -0.2% 22.19 US$50,520
2026-01-13 2026-01-13
PrS Proposed sale
2,277
22.19
US$50,520 		2,277 22.19 US$50,520
2025-01-30 2025-01-29
S Sale
826 -0.1%
29.52
US$24,386 		826 -0.1% 29.52 US$24,386
2025-01-29 2025-01-29
PrS Proposed sale
826
29.52
US$24,386 		826 29.52 US$24,386
2025-01-23 2025-01-22
S Sale
3,948 -0.3%
30.43
US$120,120 		3,948 -0.3% 30.43 US$120,120
2025-01-22 2025-01-22
PrS Proposed sale
3,948
30.43
US$120,120 		3,948 30.43 US$120,120
2025-01-21 2025-01-17
S Sale
750 -0.1%
29.96
US$22,469 		750 -0.1% 29.96 US$22,469
2025-01-17 2025-01-17
PrS Proposed sale
750
29.96
US$22,469 		750 29.96 US$22,469
2025-01-14 2025-01-13
S Sale
2,288 -0.2%
28.70
US$65,670 		2,288 -0.2% 28.70 US$65,670
2025-01-13 2025-01-13
PrS Proposed sale
2,331
28.70
US$66,891 		2,331 28.70 US$66,891
2024-05-09 2024-05-08
PlS Planned sale
100 -0.0%
44.03
US$4,402 		100 -0.0% 44.03 US$4,402
2024-05-09 2024-05-08
PlS Planned sale
22,472 -2.0%
42.85
US$962,903 		22,472 -2.0% 42.85 US$962,903
2024-05-09 2024-05-08
PlS Planned sale
56,335 -4.7%
42.15
US$2,374,543 		56,335 -4.7% 42.15 US$2,374,543
2024-05-08 2024-05-08
PrS Proposed sale
78,907
42.35
US$3,341,846 		78,907 42.35 US$3,341,846
2024-04-09 2024-04-08
PlS Planned sale
4,728 -0.4%
54.92
US$259,639 		4,728 -0.4% 54.92 US$259,639
2024-04-09 2024-04-08
PlS Planned sale
64,379 -5.4%
54.12
US$3,483,966 		64,379 -5.4% 54.12 US$3,483,966
2024-04-08 2024-04-08
PrS Proposed sale
69,107
54.17
US$3,743,606 		69,107 54.17 US$3,743,606
2024-03-11 2024-03-08
PlS Planned sale
100 -0.0%
63.35
US$6,335 		100 -0.0% 63.35 US$6,335
2024-03-11 2024-03-08
PlS Planned sale
26,257 -2.3%
62.69
US$1,646,041 		26,257 -2.3% 62.69 US$1,646,041
2024-03-11 2024-03-08
PlS Planned sale
42,750 -3.6%
61.88
US$2,645,173 		42,750 -3.6% 61.88 US$2,645,173
2024-03-08 2024-03-08
PrS Proposed sale
69,107
62.19
US$4,297,548 		69,107 62.19 US$4,297,548
2024-02-13 2024-02-12
S Sale
1,148 -0.1%
67.77
US$77,796 		1,148 -0.1% 67.77 US$77,796
2024-02-12 2024-02-12
PrS Proposed sale
1,148
67.77
US$77,796 		1,148 67.77 US$77,796
2024-01-31 2024-01-29
S Sale
874 -0.1%
64.14
US$56,057 		874 -0.1% 64.14 US$56,057
2024-01-29 2024-01-29
PrS Proposed sale
874
64.14
US$56,057 		874 64.14 US$56,057
2024-01-23 2024-01-22
S Sale
3,913 -0.3%
65.00
US$254,329 		3,913 -0.3% 65.00 US$254,329
2024-01-22 2024-01-22
PrS Proposed sale
3,913
65.00
US$254,329 		3,913 65.00 US$254,329
2024-01-17 2024-01-16
S Sale
1,632 -0.1%
66.81
US$109,032 		1,632 -0.1% 66.81 US$109,032
2024-01-16 2024-01-16
PrS Proposed sale
1,632
66.81
US$109,032 		1,632 66.81 US$109,032
2023-11-09 2023-11-08
PlS Planned sale
12,000 -1.1%
47.27
US$567,240 		12,000 -1.1% 47.27 US$567,240
2023-11-08 2023-11-08
PrS Proposed sale
12,000
47.27
US$567,240 		12,000 47.27 US$567,240
2023-10-10 2023-10-09
PrS Proposed sale
12,000
40.38
US$484,560 		12,000 40.38 US$484,560
2023-10-10 2023-10-09
PrS Proposed sale
12,000
40.38
US$484,560 		12,000 40.38 US$484,560
2023-10-10 2023-10-09
PlS Planned sale
12,000 -1.1%
40.38
US$484,560 		12,000 -1.1% 40.38 US$484,560
2023-09-11 2023-09-08
S Sale
12,000 -1.1%
42.87
US$514,440 		12,000 -1.1% 42.87 US$514,440
2023-09-08 2023-09-08
PrS Proposed sale
12,000
42.87
US$514,440 		12,000 42.87 US$514,440
2023-08-09 2023-08-08
PlS Planned sale
12,000 -1.1%
23.66
US$283,920 		12,000 -1.1% 23.66 US$283,920
2023-08-08 2023-08-08
PrS Proposed sale
12,000
23.66
US$283,920 		12,000 23.66 US$283,920
2023-07-11 2023-07-10
PlS Planned sale
12,000 -1.1%
84.55
US$1,014,600 		12,000 -1.1% 84.55 US$1,014,600
2023-07-10 2023-07-10
PrS Proposed sale
12,000
84.55
US$1,014,600 		12,000 84.55 US$1,014,600
2023-06-09 2023-06-08
PlS Planned sale
12,000 -1.1%
91.35
US$1,096,200 		12,000 -1.1% 91.35 US$1,096,200